Early stages of diagnosis and management of suspected HLH/MAS
2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome
Annals of the Rheumatic Diseases (ARD)
is a leading rheumatology journal from BMJ and EULAR, publishing original research, reviews and recommendations
Impact Factor: 27.4
Citescore: 32.8
All metrics >>
Latest EULAR Recommendations
Non-pharmacological management of SLE and SSc
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis
Management of ANCA-associated vasculitis
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
Treatment of chronic and opportunistic infections in patients with AIIRD
EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
Editor's Choice
Rheumatoid arthritis:
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial9 July 2023
Review:
Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets15 February 2023
Latest Articles
Inflammatory arthritis:
L-arginine metabolism inhibits arthritis and inflammatory bone loss29 September 2023
Rheumatoid arthritis:
Determination of the most appropriate ACR response definition for contemporary drug approval trials in rheumatoid arthritis27 September 2023
Editorials:
Annals of the Rheumatic Diseases collection on glucocorticoids (2020-2023): novel insights and advances in therapy22 September 2023
Recommendations
The EULAR Standing Committees regularly establish and publish recommendations for the treatment of various rheumatic disorders. Each of these recommendations is developed by a group of specialists in their field.
All EULAR recommendations are free to access.
Each recommendation also has an accompanying lay summary, which is also free to access.
Video
Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study
Conclusions The efficacy of BKZ in bDMARD-naïve patients with PsA was sustained from Week 16 to Week 52. BKZ was well tolerated with no new safety signals observed.
Find out moreAltmetrics
Jobs
Emergency Department Consultant Adult and Paediatric Care
Emergency Department Consultant Pre-Hospital Care
Salaried GP/Partner
Consultant Radiologist with Interest in Neuroradiology Imaging
Consultant - Eldercare / Geriatric Medicine - Parkinson's Interest
Isle of Man (GB) (IM)
We are searching for a pro-active and enthusiastic Consultant in Emergency Medicine to join our expanding team at Noble’s Hospital on the Isle of Man!Recruiter: Isle of Man Government Secondary Care
Emergency Department Consultant Pre-Hospital Care
Isle of Man (GB) (IM)
Are you looking to take the next step in your medical career in Emergency Medicine? Join our fantastic ED team here on the Isle of Man!Recruiter: Isle of Man Government Secondary Care
Salaried GP/Partner
Tonbridge, Kent
Would you like to work in a Practice recommended by 97% of our patients (Friends and Family test August 23)Recruiter: Warders Medical Centre
Consultant Radiologist with Interest in Neuroradiology Imaging
Craigavon Area Hospital
For informal queries regarding this post please contact Dr Imran Yousuf – Clinical Director of Radiology – Craigavon Area Hospital. Tel: 02837564324Recruiter: Southern Health and Social Care Trust
Consultant - Eldercare / Geriatric Medicine - Parkinson's Interest
Truro
Applications are invited for the post of Consultant Geriatrician (with an interest in Parkinson's Disease)Recruiter: Royal Cornwall Hospitals NHS Trust